tiprankstipranks
Trending News
More News >
Nichiban Co., Ltd. (JP:4218)
:4218
Japanese Market

Nichiban Co., Ltd. (4218) Price & Analysis

Compare
0 Followers

4218 Stock Chart & Stats


---

Financials

Quarterly

Options Prices

Currently, No data available
---

Ownership Overview

1.65%97.61%
Insiders
1.65%
Mutual Funds
― Other Institutional Investors
97.61% Public Companies and
Individual Investors

4218 FAQ

What was Nichiban Co., Ltd.’s price range in the past 12 months?
Nichiban Co., Ltd. lowest stock price was ¥1688.00 and its highest was ¥2155.00 in the past 12 months.
    What is Nichiban Co., Ltd.’s market cap?
    Nichiban Co., Ltd.’s market cap is ¥40.53B.
      When is Nichiban Co., Ltd.’s upcoming earnings report date?
      Nichiban Co., Ltd.’s upcoming earnings report date is May 09, 2025 which is in 15 days.
        How were Nichiban Co., Ltd.’s earnings last quarter?
        Nichiban Co., Ltd. released its earnings results on Feb 10, 2025. The company reported ¥42.35 earnings per share for the quarter, beating the consensus estimate of N/A by ¥42.35.
          Is Nichiban Co., Ltd. overvalued?
          According to Wall Street analysts Nichiban Co., Ltd.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Nichiban Co., Ltd. pay dividends?
            Nichiban Co., Ltd. pays a Annually dividend of ¥35 which represents an annual dividend yield of 1.7%. See more information on Nichiban Co., Ltd. dividends here
              What is Nichiban Co., Ltd.’s EPS estimate?
              Nichiban Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Nichiban Co., Ltd. have?
              Nichiban Co., Ltd. has 20,738,007 shares outstanding.
                What happened to Nichiban Co., Ltd.’s price movement after its last earnings report?
                Nichiban Co., Ltd. reported an EPS of ¥42.35 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -4.654%.
                  Which hedge fund is a major shareholder of Nichiban Co., Ltd.?
                  Currently, no hedge funds are holding shares in JP:4218
                  ---

                  Company Description

                  Nichiban Co., Ltd.

                  Nichiban Co., Ltd. manufactures and sells medical products and tapes in Asia and Europe. It offers medical products, including surgical tapes, dressing tapes, first-aid bandages, hemostatic bandages, and others. The company also provides OTC products, such as anti-inflammatory patches, foot care products, waterproof films, and bandages. In addition, it offers taping tapes comprising cotton, elastic, kinesiology, strapping tapes, and others; and stationery products consisting of cellulose adhesive tapes, double sided tapes, adhesive transfer tapes, book binding tapes, and others. Further, the company provides industrial tapes for non-heavy duty packaging, carton boxes, agricultural use, vehicles, and machinery, as well as specialized tapes; and cellulose, OPP packing, kraft paper, lithographic, and crepe tapes. Nichiban Co., Ltd. was founded in 1918 and is headquartered in Tokyo, Japan.
                  ---

                  4218 Stock 12 Month Forecast

                  Average Price Target

                  ¥2,850.00
                  ▲(38.28% Upside)
                  {"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1673":"¥1,673","2262":"¥2,262","2851":"¥2,851","1967.5":"¥1,967.5","2556.5":"¥2,556.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":2850,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">¥2.85K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2850,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">¥2.85K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2850,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">¥2.85K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1673,1967.5,2262,2556.5,2851],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Apr<br/>2024","6":"Jul<br/>2024","9":"Oct<br/>2024","12":"Dec<br/>2024","25":"Dec<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1893.74,1967.2984615384617,2040.856923076923,2114.4153846153845,2187.9738461538464,2261.5323076923078,2335.090769230769,2408.6492307692306,2482.2076923076925,2555.766153846154,2629.3246153846153,2702.883076923077,2776.4415384615386,{"y":2850,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1893.74,1967.2984615384617,2040.856923076923,2114.4153846153845,2187.9738461538464,2261.5323076923078,2335.090769230769,2408.6492307692306,2482.2076923076925,2555.766153846154,2629.3246153846153,2702.883076923077,2776.4415384615386,{"y":2850,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1893.74,1967.2984615384617,2040.856923076923,2114.4153846153845,2187.9738461538464,2261.5323076923078,2335.090769230769,2408.6492307692306,2482.2076923076925,2555.766153846154,2629.3246153846153,2702.883076923077,2776.4415384615386,{"y":2850,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1674.87,"date":1704067200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1685.5,"date":1706745600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1820.8,"date":1709251200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1942.92,"date":1711929600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1873.08,"date":1714521600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1757.98,"date":1717200000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1875.04,"date":1719792000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1834.71,"date":1722470400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1925.22,"date":1725148800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1896.69,"date":1727740800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1895.7,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1893.74,"date":1733011200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1893.74,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  T Hasegawa Co
                  Kobayashi Pharmaceutical Co
                  Kissei Pharmaceutical Co
                  Shiseido Company,Limited
                  S.T.Corporation

                  Best Analysts Covering 4218

                  1 Year
                  1 Year Success Rate
                  0/1 ratings generated profit
                  0%
                  1 Year Average Return
                  -2.80%
                  reiterated a buy rating 5 months ago
                  Copying Yasuhiro Narita's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -2.80% per trade.
                  Popular Stocks
                  ---
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis